Lyxumia could expedite moving patients to final drug dose

09/12/2011 | Bloomberg

A study of 482 patients with diabetes who used Sanofi's experimental Lyxumia found the drug improved blood-glucose levels when the dosage was doubled after two weeks or increased over three weeks, experts reported at the European Association for the Study of Diabetes conference. The drug, which also helped patients lose weight, could help doctors more quickly advance patients to the ideal drug dosing.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY